Affordable Access

deepdyve-link
Publisher Website

Radiotherapy-induced nausea and vomiting.

Authors
  • Dennis, Kristopher1
  • Maranzano, Ernesto
  • De Angelis, Carlo
  • Holden, Lori
  • Wong, Shun
  • Chow, Edward
  • 1 Radiation Oncology and Pharmacy Departments, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, Canada. , (Canada)
Type
Published Article
Journal
Expert review of pharmacoeconomics & outcomes research
Publication Date
Dec 01, 2011
Volume
11
Issue
6
Pages
685–692
Identifiers
DOI: 10.1586/erp.11.77
PMID: 22098284
Source
Medline
License
Unknown

Abstract

Radiotherapy-induced nausea and vomiting (RINV) are common and troublesome symptoms experienced by patients undergoing radiotherapy. Although quality of life and symptom control now figure prominently in evaluations of cancer therapies, progress in RINV research and clinical prevention has been slow. This article summarizes the major guidelines for the prevention of RINV; their structure, recommendations, evidence base and notable issues. It also examines the current challenges and controversies related to RINV clinical management and research, and provides possible solutions for them that could ultimately lead to better patient care.

Report this publication

Statistics

Seen <100 times